Anette Duensing相关文献与解析，生知库 | 链接生命科学的每一步

Ourailidis, Iordanis; Ball, Markus; Vogel, Vanessa; He, Min; Wang, Hairong; Kim, Stella Beomseo; Böning, Sarah; Wollenberg, Barbara; Wolff, Klaus Dietrich; Steiger, Katja; Mogler, Carolin; Duensing, Anette; Duensing, Stefan; Schirmacher, Peter; Stenzinger, Albrecht; Gires, Olivier; Kazdal, Daniel; Kirchner, Martina; Stögbauer, Fabian; Boxberg, Melanie; Budczies, Jan

肿瘤

肿瘤免疫

头颈癌

发表日期：2026

文献求助收藏

DATA 5.0-Data Acquisition, Translation & Analysis-a prospective urooncological data warehouse for the 21st century

数据5.0——数据采集、转换与分析——面向21世纪的泌尿肿瘤学数据仓库

期刊:Frontiers in Digital Health

影响因子:3.8

doi:10.3389/fdgth.2025.1530321

Schütz, Viktoria; Geisler, Christine; Rath, Mathias; Böning, Sarah; Treber, Thomas; Stenzinger, Albrecht; Brobeil, Alexander; Reinhard, Oliver; Duensing, Anette; Duensing, Stefan; Hohenfellner, Markus; Görtz, Magdalena

Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD

数字空间分析将肿瘤中心识别为前列腺癌的拓扑微环境，其特征是 BAD 的上调

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-024-71070-6

Ann-Kathrin Huber, Adam Kaczorowski, Felix Schneider, Sarah Böning, Magdalena Görtz, David Langhoff, Constantin Schwab, Albrecht Stenzinger, Markus Hohenfellner, Anette Duensing, Stefan Duensing

PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study

PD-L1 作为肾细胞癌尿液生物标志物 - 病例系列和概念验证研究

期刊:Diagnostics

影响因子:

doi:10.3390/diagnostics14070741

Philipp Reimold, Georgi Tosev, Adam Kaczorowski, Jana Friedhoff, Constantin Schwab, Viktoria Schütz, Magdalena Görtz, Niklas Panzer, Martina Heller, Cem Aksoy, Ruth Himmelsbach, Thomas Walle, Stefanie Zschäbitz, Dirk Jäger, Anette Duensing, Albrecht Stenzinger, Markus Hohenfellner, Stefan Duensing

BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study

BAP1 和 PTEN 突变塑造透明细胞肾细胞癌的免疫学景观并揭示 T 细胞抑制的肿瘤间异质性：一项概念验证研究

期刊:Cancer Immunology Immunotherapy

影响因子:8.1

doi:10.1007/s00262-022-03346-7

Jana Friedhoff, Felix Schneider, Christina Jurcic, Volker Endris, Martina Kirchner, Angela Sun, Iulia Bolnavu, Laura Pohl, Miriam Teroerde, Maximilian Kippenberger, Constantin Schwab, Adam Kaczorowski, Stefanie Zschäbitz, Dirk Jäger, Markus Hohenfellner, Albrecht Stenzinger #, Anette Duensing #, Ste

Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma

T1N0M1 期肾细胞癌患者的长期生存率

期刊:Cancers

影响因子:

doi:10.3390/cancers15245715

Viktoria Schütz, Huan Lin, Adam Kaczorowski, Stefanie Zschäbitz, Dirk Jäger, Albrecht Stenzinger, Anette Duensing, Jürgen Debus, Markus Hohenfellner, Stefan Duensing

Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma

数字空间分析确定肿瘤外围是透明细胞肾细胞癌中高度活跃的生物微环境

期刊:Cancers

影响因子:

doi:10.3390/cancers15205050

Felix Schneider, Adam Kaczorowski, Christina Jurcic, Martina Kirchner, Constantin Schwab, Viktoria Schütz, Magdalena Görtz, Stefanie Zschäbitz, Dirk Jäger, Albrecht Stenzinger, Markus Hohenfellner, Stefan Duensing, Anette Duensing

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities

肾癌模型在临床前药物发现中的应用：挑战与机遇

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2022.889686

Pohl, Laura; Friedhoff, Jana; Jurcic, Christina; Teroerde, Miriam; Schindler, Isabella; Strepi, Konstantina; Schneider, Felix; Kaczorowski, Adam; Hohenfellner, Markus; Duensing, Anette; Duensing, Stefan

Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery

晚期肾细胞癌中蛋白酶体的靶向治疗：患者个体化临床前药物研发的复杂性和局限性

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines9060627

Jielin Li, Laura Pohl, Julia Schüler, Nina Korzeniewski, Philipp Reimold, Adam Kaczorowski, Weibin Hou, Stefanie Zschäbitz, Cathleen Nientiedt, Dirk Jäger, Markus Hohenfellner, Anette Duensing, Stefan Duensing

Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas

去分化软骨肉瘤两种成分中血管生成标志物 HSP70、HSP90、VEGF 和 pERK1/2 的差异表达

期刊:Journal of Bone Oncology

影响因子:3.1

doi:10.1016/j.jbo.2021.100370

Karen Schoedel, Virginia Miller, David Osei-Hwedieh, Rebecca Watters, Anette Duensing, Ivy John, Uma Chandran, Alexander Chang, Vishal Soman, Kurt Weiss

Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancer

空间转录组学揭示头颈癌中肿瘤出芽的分子特征

DATA 5.0-Data Acquisition, Translation & Analysis-a prospective urooncological data warehouse for the 21st century

数据5.0——数据采集、转换与分析——面向21世纪的泌尿肿瘤学数据仓库

Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD

数字空间分析将肿瘤中心识别为前列腺癌的拓扑微环境，其特征是 BAD 的上调

PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study

PD-L1 作为肾细胞癌尿液生物标志物 - 病例系列和概念验证研究

BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study

BAP1 和 PTEN 突变塑造透明细胞肾细胞癌的免疫学景观并揭示 T 细胞抑制的肿瘤间异质性：一项概念验证研究

Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma

T1N0M1 期肾细胞癌患者的长期生存率

Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma

数字空间分析确定肿瘤外围是透明细胞肾细胞癌中高度活跃的生物微环境

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities

肾癌模型在临床前药物发现中的应用：挑战与机遇

Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery

晚期肾细胞癌中蛋白酶体的靶向治疗：患者个体化临床前药物研发的复杂性和局限性

Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas

去分化软骨肉瘤两种成分中血管生成标志物 HSP70、HSP90、VEGF 和 pERK1/2 的差异表达